Do Oral GLP-1s Work as Well as Injections? What the Clinical Data Shows
The most common question about oral GLP-1s: do they work as well as injections? The answer depends on which oral product you're talking about.
FDA-Approved Oral Semaglutide vs Injectable
Oral semaglutide (the molecule in Wegovy/Rybelsus) has been studied head-to-head against its injectable version. The clinical data shows that at equivalent therapeutic doses, oral and injectable semaglutide produce comparable reductions in blood sugar (HbA1c) and body weight. The OASIS and PIONEER trial programs demonstrated this across thousands of patients.
The oral formulation requires higher milligram doses to achieve the same blood levels — a consequence of the ~1% oral bioavailability. But the end result in terms of weight loss and metabolic improvement is comparable when properly dosed.
Foundayo (Orforglipron) vs Injectable GLP-1s
Foundayo achieved 12.4% average weight loss at the highest approved dose in clinical trials. For context, injectable semaglutide (Wegovy) typically achieves 15–17% weight loss, and injectable tirzepatide (Zepbound) achieves 18–22%. Foundayo's weight loss is meaningful and clinically significant, but it's lower than the best injectable results.
However, Foundayo's no-food-restriction convenience and daily oral dosing may lead to better real-world adherence, which could narrow the gap in practice. A drug you actually take consistently can outperform a "better" drug you skip.
Compounded Oral GLP-1s: Limited Data
This is where honesty gets uncomfortable for the compounding industry. There are no published Phase 3 clinical trials validating the efficacy of compounded sublingual, buccal, or dissolvable oral semaglutide. The clinical evidence base for these products comes from the injectable semaglutide trials — not from studies of the specific oral formulations patients are actually taking.
Anecdotal reports from providers and patients suggest that compounded oral GLP-1s do produce weight loss, appetite suppression, and blood sugar improvements. But the magnitude and consistency of these effects, compared to injectable or FDA-approved oral formulations, hasn't been rigorously measured.